Molecular diagnostics, also known as molecular pathology, involves taking the unique genetic code, DNA or RNA, found in cells and analyzing the sequences for red flags that can identify potential occurrences of certain diseases. included. This field has expanded rapidly in recent years. Molecular diagnostics are increasingly being used to guide patient management from diagnosis to treatment, especially in the fields of cancer, infectious diseases, and congenital anomalies.
Allied Market Research has published a study report with the title Molecular Diagnostics Market Size was Valued at USD 536.9 million in 2021 and is Projected to Garner USD 1.09 billion by 2031 registering a CAGR of 7.4% from 2022 to 2031.
Covid-19 Scenario-
- Surge in Covid-19 cases led to a steep incline in demand for real-time polymerase chain reaction (RT-PCR) test to detect COVID-19, thereby impacting the global molecular diagnostics market positively.
- This trend is most likely to continue till the pandemic is completely over.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/2170
Top Companies of Molecular Diagnostics: –
- Abbott Laboratories
- Becton
- F. Hoffmann-La Roche AG
- Qiagen N.V.
- Hologic Corporation
- Grifols
- Danaher Corporation, S.A.
- Agilent Inc.
- Dickinson and Company
- BioMérieux SA
- Siemens Healthcare GmbH
Molecular Diagnostics Market Segmentation: –
By Type
- Instruments
- Reagents
- Software & Services
By Technology
- Polymerase Chain Reaction (PCR)
- Hybridization
- DNA sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
By Application
- Infectious diseases
- Oncology
- Genetic testing
- Blood screening
- Others
By End User
- Hospital
- Reference Labortories
- Others
Based on region, North America, held the major share in 2020, generating more than two-fifths of the global molecular diagnostics market, due to the presence of large number of key players across the region. At the same time, the market across Asia-Pacific would grow at the fastest CAGR of 10.78% by 2030, owing to higher adoption & increased use of molecular diagnostics, rapidly growing geriatric population, and rise in the incidence of infectious diseases across the province.
Drivers, restraints, and opportunities-
Increase in the prevalence of infectious diseases and various types of cancer drives the growth of the molecular diagnostics market. On the other hand, stringent regulatory requirements for the approval of new molecular diagnostics techniques are expected to hinder the growth of the market. However, surge in adoption of the molecular diagnostics in emerging economies is projected to offer numerous opportunities in the industry.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/2170
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
North America
⦁ U.S.
⦁ Canada
⦁ Mexico
Europe
⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe
Asia-Pacific
⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific
LAMEA
⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA
Top Trending Report:
- Wireless Brain Sensors Market
- Autologous Cell Therapy Market
- Magnetic Resonance Imaging (MRI) Coils Market
- Duchenne Muscular Dystrophy Market
- Toxoplasmosis Treatment Market
Contact Details:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.